1 / 1

New clinical trial for adolescents and adults with Fragile X Syndrome 14-50 years of age

New clinical trial for adolescents and adults with Fragile X Syndrome 14-50 years of age. PURPOSE : to study the effectiveness and safety of a new drug that is being developed to improve the symptoms of Fragile X Syndrome . Sponsored by Pharmaceuticals.

taariq
Télécharger la présentation

New clinical trial for adolescents and adults with Fragile X Syndrome 14-50 years of age

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. New clinical trial for adolescents and adults with Fragile X Syndrome14-50 years of age PURPOSE: to study the effectiveness and safety of a new drug that is being developed to improve the symptoms of Fragile X Syndrome Sponsored by Pharmaceuticals Taking place at The Kennedy Krieger Institute, Baltimore, Maryland PI: Michael V. Johnston, MD Kennedy Krieger Institute Approved May 8, 2013 Co-I: Dejan Budimirovic, MD Director, Fragile X Clinic Kennedy Krieger Institute Co-I: Tanjala Gipson, MD Kennedy Krieger Institute This research study is free. You will be given $50 for reimbursement for travel and related expenses for each completed visit. Call 443-923-7619 for more information. Protocol Number: NA_00049393

More Related